TF and cancer: Independent clinical studies found a greater amount of TF+ MVs and higher TF activity associated with MVs in cancer patients with venous thrombosis compared to patients without venous thrombosis [246,247,248,249,250] and showed that cancer patients with higher TF+ MVs levels have a higher risk of developing VTE [251,252].